Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus

Identifieur interne : 001075 ( Main/Exploration ); précédent : 001074; suivant : 001076

In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus

Auteurs : L. Cegolon [Italie, Royaume-Uni] ; C. Salata [Italie] ; E. Piccoli [Italie] ; V. Juarez [France] ; G. Palu' [Italie] ; G. Mastrangelo [Italie] ; A. Calistri [Italie]

Source :

RBID : Pascal:14-0075821

Descripteurs français

English descriptors

Abstract

Influenza virus spreads via small particle aerosols, droplets and fomites, and since it can survive for a short time on surfaces, can be introduced into the nasal mucosa before it loses infectivity. The hypothiocyanite ion (OSCN-), product of the lactoperoxidase/H2O2/SCN- system of central airways, is emerging as an important molecule for innate defense mechanism against bacteria, fungi and viruses. Here we demonstrated that OSCN- displays virucidal activity in vitro against the A/H1N1 2009 pandemic influenza virus. The concentration required to inhibit viral replication by 50% was 2 μM when virus were challenged directly with OSCN- before cell inoculation. These values were even lower when inoculated cells were maintained in contact with enzyme free-OSCN- in the culture medium. The last experimental conditions better reflect those of tracheobronchial mucosa, where HOSCN/OSCN- is retained in the air-liquid interface and inactivates both the viruses approaching the epithelium from outside and those released from the inoculated cells after the replication cycle. Importantly no OSCN- cytotoxicity was observed in the cellular system employed. The lack of toxicity in humans and the absence of damage on surfaces of fomites suggest a potential use of OSCN- to avoid mucosal and environmental transmission of influenza virus. Since hypothiocyanite is normally present in human airways a low risk of viral resistance is envisaged. In vivo confirmatory studies are needed to evaluate the appropriate dose, regimen and formulation.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus</title>
<author>
<name sortKey="Cegolon, L" sort="Cegolon, L" uniqKey="Cegolon L" first="L." last="Cegolon">L. Cegolon</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Imperial College London, School of Public Health, St. Mary's Campus</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Salata, C" sort="Salata, C" uniqKey="Salata C" first="C." last="Salata">C. Salata</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Piccoli, E" sort="Piccoli, E" uniqKey="Piccoli E" first="E." last="Piccoli">E. Piccoli</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Juarez, V" sort="Juarez, V" uniqKey="Juarez V" first="V." last="Juarez">V. Juarez</name>
<affiliation wicri:level="3">
<inist:fA14 i1="03">
<s1>Alaxia SAS</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Palu, G" sort="Palu, G" uniqKey="Palu G" first="G." last="Palu'">G. Palu'</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mastrangelo, G" sort="Mastrangelo, G" uniqKey="Mastrangelo G" first="G." last="Mastrangelo">G. Mastrangelo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Calistri, A" sort="Calistri, A" uniqKey="Calistri A" first="A." last="Calistri">A. Calistri</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">14-0075821</idno>
<date when="2014">2014</date>
<idno type="stanalyst">PASCAL 14-0075821 INIST</idno>
<idno type="RBID">Pascal:14-0075821</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000145</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001C73</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000084</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000084</idno>
<idno type="wicri:doubleKey">1438-4639:2014:Cegolon L:in:vitro:antiviral</idno>
<idno type="wicri:Area/Main/Merge">001085</idno>
<idno type="wicri:Area/Main/Curation">001075</idno>
<idno type="wicri:Area/Main/Exploration">001075</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus</title>
<author>
<name sortKey="Cegolon, L" sort="Cegolon, L" uniqKey="Cegolon L" first="L." last="Cegolon">L. Cegolon</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Imperial College London, School of Public Health, St. Mary's Campus</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Salata, C" sort="Salata, C" uniqKey="Salata C" first="C." last="Salata">C. Salata</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Piccoli, E" sort="Piccoli, E" uniqKey="Piccoli E" first="E." last="Piccoli">E. Piccoli</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Juarez, V" sort="Juarez, V" uniqKey="Juarez V" first="V." last="Juarez">V. Juarez</name>
<affiliation wicri:level="3">
<inist:fA14 i1="03">
<s1>Alaxia SAS</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Palu, G" sort="Palu, G" uniqKey="Palu G" first="G." last="Palu'">G. Palu'</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mastrangelo, G" sort="Mastrangelo, G" uniqKey="Mastrangelo G" first="G." last="Mastrangelo">G. Mastrangelo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Calistri, A" sort="Calistri, A" uniqKey="Calistri A" first="A." last="Calistri">A. Calistri</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">International journal of hygiene and environmental health</title>
<title level="j" type="abbreviated">Int. j. hyg. environ. health : (print)</title>
<idno type="ISSN">1438-4639</idno>
<imprint>
<date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">International journal of hygiene and environmental health</title>
<title level="j" type="abbreviated">Int. j. hyg. environ. health : (print)</title>
<idno type="ISSN">1438-4639</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>2009</term>
<term>Antiviral</term>
<term>Biological activity</term>
<term>Check</term>
<term>Disinfection</term>
<term>Environmental medicine</term>
<term>H1N1 influenza</term>
<term>Health and environment</term>
<term>In vitro</term>
<term>Infection</term>
<term>Influenzavirus</term>
<term>Prevention</term>
<term>Public health</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Infection</term>
<term>Activité biologique</term>
<term>In vitro</term>
<term>Antiviral</term>
<term>2009</term>
<term>Santé publique</term>
<term>Influenzavirus</term>
<term>Prévention</term>
<term>Traitement</term>
<term>Contrôle</term>
<term>Désinfection</term>
<term>Santé et environnement</term>
<term>Médecine environnementale</term>
<term>Pandémie</term>
<term>Grippe H1N1</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Santé publique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Influenza virus spreads via small particle aerosols, droplets and fomites, and since it can survive for a short time on surfaces, can be introduced into the nasal mucosa before it loses infectivity. The hypothiocyanite ion (OSCN
<sup>-</sup>
), product of the lactoperoxidase/H
<sub>2</sub>
O
<sub>2/</sub>
SCN
<sup>-</sup>
system of central airways, is emerging as an important molecule for innate defense mechanism against bacteria, fungi and viruses. Here we demonstrated that OSCN
<sup>-</sup>
displays virucidal activity in vitro against the A/H1N1 2009 pandemic influenza virus. The concentration required to inhibit viral replication by 50% was 2 μM when virus were challenged directly with OSCN
<sup>-</sup>
before cell inoculation. These values were even lower when inoculated cells were maintained in contact with enzyme free-OSCN
<sup>-</sup>
in the culture medium. The last experimental conditions better reflect those of tracheobronchial mucosa, where HOSCN/OSCN
<sup>-</sup>
is retained in the air-liquid interface and inactivates both the viruses approaching the epithelium from outside and those released from the inoculated cells after the replication cycle. Importantly no OSCN
<sup>-</sup>
cytotoxicity was observed in the cellular system employed. The lack of toxicity in humans and the absence of damage on surfaces of fomites suggest a potential use of OSCN
<sup>-</sup>
to avoid mucosal and environmental transmission of influenza virus. Since hypothiocyanite is normally present in human airways a low risk of viral resistance is envisaged. In vivo confirmatory studies are needed to evaluate the appropriate dose, regimen and formulation.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
<li>Italie</li>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Auvergne-Rhône-Alpes</li>
<li>Grand Londres</li>
<li>Rhône-Alpes</li>
</region>
<settlement>
<li>Londres</li>
<li>Lyon</li>
</settlement>
</list>
<tree>
<country name="Italie">
<noRegion>
<name sortKey="Cegolon, L" sort="Cegolon, L" uniqKey="Cegolon L" first="L." last="Cegolon">L. Cegolon</name>
</noRegion>
<name sortKey="Calistri, A" sort="Calistri, A" uniqKey="Calistri A" first="A." last="Calistri">A. Calistri</name>
<name sortKey="Mastrangelo, G" sort="Mastrangelo, G" uniqKey="Mastrangelo G" first="G." last="Mastrangelo">G. Mastrangelo</name>
<name sortKey="Palu, G" sort="Palu, G" uniqKey="Palu G" first="G." last="Palu'">G. Palu'</name>
<name sortKey="Piccoli, E" sort="Piccoli, E" uniqKey="Piccoli E" first="E." last="Piccoli">E. Piccoli</name>
<name sortKey="Salata, C" sort="Salata, C" uniqKey="Salata C" first="C." last="Salata">C. Salata</name>
</country>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Cegolon, L" sort="Cegolon, L" uniqKey="Cegolon L" first="L." last="Cegolon">L. Cegolon</name>
</region>
</country>
<country name="France">
<region name="Auvergne-Rhône-Alpes">
<name sortKey="Juarez, V" sort="Juarez, V" uniqKey="Juarez V" first="V." last="Juarez">V. Juarez</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001075 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001075 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:14-0075821
   |texte=   In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021